Christopher I. Li

17.2k total citations · 3 hit papers
196 papers, 10.2k citations indexed

About

Christopher I. Li is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Christopher I. Li has authored 196 papers receiving a total of 10.2k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Oncology, 68 papers in Cancer Research and 53 papers in Genetics. Recurrent topics in Christopher I. Li's work include Cancer Risks and Factors (71 papers), Breast Cancer Treatment Studies (55 papers) and Estrogen and related hormone effects (40 papers). Christopher I. Li is often cited by papers focused on Cancer Risks and Factors (71 papers), Breast Cancer Treatment Studies (55 papers) and Estrogen and related hormone effects (40 papers). Christopher I. Li collaborates with scholars based in United States, South Africa and Germany. Christopher I. Li's co-authors include Janet R. Daling, Kathleen E. Malone, Peggy L. Porter, Mary Anne Rossing, Lisa K. Dunnwald, Roger E. Moe, Benjamin O. Anderson, Vivien W. Chen, Sean F. Altekruse and Kathleen A. Cronin and has published in prestigious journals such as JAMA, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Christopher I. Li

189 papers receiving 9.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status

2014 1.0k citations Christopher I. Li et al. JNCI Journal of the National Cancer Institute profile →
Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients

2007 580 citations Christopher I. Li et al. profile →
Differences in Breast Cancer Stage, Treatment, and Survival by Race and Ethnicity

2003 557 citations Christopher I. Li, Kathleen E. Malone et al. profile →

Peers

Christopher I. Li

ONCOL

GENET

PRM

Paul E. Goss United States

Melissa A. Troester United States

Kathleen E. Malone United States

Patricia G. Moorman United States

Giske Ursin United States

Vivianne C. G. Tjan‐Heijnen Netherlands

Dezheng Huo United States

Maureen Trudeau Canada

Kamila Czene Sweden

Gershon Y. Locker United States

Paul E. Goss United States

Christopher I. Li

5.4k ×0.9

ONCOL

3.8k ×1.0

3.7k ×1.7

GENET

2.3k ×1.2

2.1k ×1.3

PRM

Citations per year, relative to Christopher I. Li Christopher I. Li (= 1×) peers Paul E. Goss

Countries citing papers authored by Christopher I. Li

Since Specialization

Citations

This map shows the geographic impact of Christopher I. Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher I. Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher I. Li more than expected).

Fields of papers citing papers by Christopher I. Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher I. Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher I. Li. The network helps show where Christopher I. Li may publish in the future.

Co-authorship network of co-authors of Christopher I. Li

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher I. Li. A scholar is included among the top collaborators of Christopher I. Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher I. Li. Christopher I. Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Byrd, Doratha A., Maria F. Gomez, Tengda Lin, et al.. (2025). The gut microbiome is associated with disease‐free survival in stage I–III colorectal cancer patients. International Journal of Cancer. 157(1). 64–73. 2 indexed citations

Jeong, Daniel, A Richards, Maria F. Gomez, et al.. (2025). Comparison of volumetric and single-slice computed tomography body composition metrics for colorectal cancer survival. European Journal of Radiology. 190. 112241–112241.

Oviedo, Felipe, Yixi Xu, Robert A. Vandermeulen, et al.. (2025). Cancer Detection in Breast MRI Screening via Explainable AI Anomaly Detection. Radiology. 316(1). e241629–e241629. 2 indexed citations

Malone, Kathleen E., et al.. (2024). Statin use and risks of breast cancer recurrence and mortality. Cancer. 130(18). 3106–3114. 4 indexed citations

Li, Christopher I., et al.. (2024). Executing plans to enhance diversity across cancer centers in the United States: opportunities and challenges. JNCI Journal of the National Cancer Institute. 116(8). 1198–1205. 1 indexed citations

Yu, Ming, Kelly Carter, Kelsey K. Baker, et al.. (2023). Elevated EVL Methylation Level in the Normal Colon Mucosa Is a Potential Risk Biomarker for Developing Recurrent Adenomas. Cancer Epidemiology Biomarkers & Prevention. 32(9). 1146–1152. 3 indexed citations

Ose, Jennifer, Biljana Gigic, Sheetal Hardikar, et al.. (2022). Presurgery Adhesion Molecules and Angiogenesis Biomarkers Are Differently Associated with Outcomes in Colon and Rectal Cancer: Results from the ColoCare Study. Cancer Epidemiology Biomarkers & Prevention. 31(8). 1650–1660. 2 indexed citations

Walker, Brandon S., Jennifer Ose, Christopher I. Li, et al.. (2021). Can Cost-effectiveness Analysis Inform Genotype-Guided Aspirin Use for Primary Colorectal Cancer Prevention?. Cancer Epidemiology Biomarkers & Prevention. 30(6). 1106–1113. 2 indexed citations

Schmitt, Felix C. F., Martin Schneider, Markus A. Weigand, et al.. (2021). Postoperative Complications Are Associated with Long-Term Changes in the Gut Microbiota Following Colorectal Cancer Surgery. Life. 11(3). 246–246. 11 indexed citations

10.

McDougall, Jean A., Linda S. Cook, Mei‐Tzu C. Tang, et al.. (2020). Determinants of Guideline-Discordant Breast Cancer Care. Cancer Epidemiology Biomarkers & Prevention. 30(1). 61–70. 3 indexed citations

11.

Luebeck, E. Georg, William D. Hazelton, Kit Curtius, et al.. (2018). Implications of Epigenetic Drift in Colorectal Neoplasia. Cancer Research. 79(3). 495–504. 24 indexed citations

12.

Chen, Lü, Jessica Chubak, Denise M. Boudreau, et al.. (2017). Use of Antihypertensive Medications and Risk of Adverse Breast Cancer Outcomes in a SEER–Medicare Population. Cancer Epidemiology Biomarkers & Prevention. 26(11). 1603–1610. 27 indexed citations

13.

Chen, Lu, Jessica Chubak, Denise M. Boudreau, et al.. (2017). Diabetes Treatments and Risks of Adverse Breast Cancer Outcomes among Early-Stage Breast Cancer Patients: A SEER-Medicare Analysis. Cancer Research. 77(21). 6033–6041. 32 indexed citations

14.

Zhang, Yuzheng, Christopher I. Li, Anna Lokshin, et al.. (2015). Cross-Species Antibody Microarray Interrogation Identifies a 3-Protein Panel of Plasma Biomarkers for Early Diagnosis of Pancreas Cancer. Clinical Cancer Research. 21(7). 1764–1771. 38 indexed citations

15.

Pepe, Margaret S., Christopher I. Li, & Ziding Feng. (2015). Improving the Quality of Biomarker Discovery Research: The Right Samples and Enough of Them. Cancer Epidemiology Biomarkers & Prevention. 24(6). 944–950. 42 indexed citations

16.

Beaber, Elisabeth F., Kathleen E. Malone, Mei-Tzu C. Tang, et al.. (2014). Oral Contraceptives and Breast Cancer Risk Overall and by Molecular Subtype Among Young Women. Cancer Epidemiology Biomarkers & Prevention. 23(5). 755–764. 53 indexed citations

17.

Amon, Lynn M., Sharon J. Pitteri, Christopher I. Li, et al.. (2012). Concordant Release of Glycolysis Proteins into the Plasma Preceding a Diagnosis of ER+ Breast Cancer. Cancer Research. 72(8). 1935–1942. 26 indexed citations

18.

Huang, Yi, Kathleen E. Malone, Kara L. Cushing‐Haugen, Janet R. Daling, & Christopher I. Li. (2011). Relationship between Menopausal Symptoms and Risk of Postmenopausal Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. 20(2). 379–388. 19 indexed citations

19.

Pitteri, Sharon J., Lynn M. Amon, Yuzheng Zhang, et al.. (2010). Detection of Elevated Plasma Levels of Epidermal Growth Factor Receptor Before Breast Cancer Diagnosis among Hormone Therapy Users. Cancer Research. 70(21). 8598–8606. 36 indexed citations

20.

Loo, Lenora W. M., Douglas I. Grove, Eleanor Williams, et al.. (2004). Array Comparative Genomic Hybridization Analysis of Genomic Alterations in Breast Cancer Subtypes. Cancer Research. 64(23). 8541–8549. 173 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact